Literature DB >> 7902418

Copper(II) complexes of dipeptides containing aspartyl, glutamyl, and histidyl residues in the side chain.

I Sóvágó1, E Farkas, C Bertalan, A Lebkiri, T Kowalik-Jankowska, H Kozlowski.   

Abstract

Copper(II) complexes of various dipeptides containing carboxylate and imidazole-N3 donors (alpha- and gamma-GluVal, alpha- and beta-AspGly, beta-AspHis, gamma-GluHis, and homocarnosine) were studied by potentiometric and spectroscopic methods in solution. It was found that the presence of an alpha-carboxylate group in the N-terminal part of a peptide molecule significantly enhances the metal-binding ability of the ligands as a consequence of stable bis complex formation involving amino acid-like coordination. The interaction of copper(II) with beta-AspHis was characterized by the formation of an imidazole-bridged dimeric species, while the formation of bis complexes was detected in the case of gamma-GluHis. Binding of the imidazole N3 and deprotonated amide nitrogen was presumed in the copper(II)-homocarnosine system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902418     DOI: 10.1016/0162-0134(93)85004-r

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

1.  Binding of copper(II) to thyrotropin-releasing hormone (TRH) and its analogs.

Authors:  Rong Meng; James Becker; Fu-Tyan Lin; Sunil Saxena; Stephen G Weber
Journal:  Inorganica Chim Acta       Date:  2005-06-15       Impact factor: 2.545

2.  Binding of Divalent Metal Ions with Deprotonated Peptides: Do Gas-Phase Anions Parallel the Condensed Phase?

Authors:  Robert C Dunbar; Jonathan Martens; Giel Berden; Jos Oomens
Journal:  J Phys Chem A       Date:  2018-06-13       Impact factor: 2.781

3.  Thermodynamic and structural characterization of the copper(II) complexes of peptides containing both histidyl and aspartyl residues.

Authors:  Csilla Kállay; Zoltán Nagy; Katalin Várnagy; Gerasimos Malandrinos; Nick Hadjiliadis; Imre Sóvágó
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.